These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34054234)

  • 1. Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B.
    Madhavan A; Sachu A; Balakrishnan AK; Balakrishnan S; Vasudevapanicker J
    J Lab Physicians; 2021 Mar; 13(1):1-5. PubMed ID: 34054234
    [No Abstract]   [Full Text] [Related]  

  • 2. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection among Egyptian blood donors.
    Said ZN; Sayed MH; Salama II; Aboel-Magd EK; Mahmoud MH; Setouhy ME; Mouftah F; Azzab MB; Goubran H; Bassili A; Esmat GE
    World J Hepatol; 2013 Feb; 5(2):64-73. PubMed ID: 23646231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study.
    Sen S; Panda SP; Shanmuganandan K; Gupta R; Praharaj A
    Med J Armed Forces India; 2012 Jan; 68(1):16-9. PubMed ID: 24669033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety.
    Fasola FA; Fowotade AA; Faneye AO; Adeleke A
    Afr J Lab Med; 2022; 11(1):1434. PubMed ID: 35937767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are current screening protocols for chronic hepatitis B virus infection adequate?
    Mortensen E; Kamali A; Schirmer PL; Lucero-Obusan C; Winston CA; Oda G; Winters MA; Durfee J; Martinello RA; Davey VJ; Holodniy M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):159-67. PubMed ID: 27009896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.
    Fopa D; Candotti D; Tagny CT; Doux C; Mbanya D; Murphy EL; Kenawy HI; El Chenawi F; Laperche S
    Blood Transfus; 2019 Nov; 17(6):403-408. PubMed ID: 31846605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
    Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HBc Screening of Blood Donors in Bangladesh: Relevance to Containment of HBV Propagation.
    Jahan M; Islam MA; Akbar SM; Takahashi K; Tabassum S; Rahman A; Haque MA; Biswas J; Mishiro S; Al-Mahtab M
    J Clin Exp Hepatol; 2016 Jun; 6(2):115-8. PubMed ID: 27493459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
    Hennig H; Puchta I; Luhm J; Schlenke P; Goerg S; Kirchner H
    Blood; 2002 Oct; 100(7):2637-41. PubMed ID: 12239179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safer Blood Supply for Transfusion: Which Algorithm Should Be Used to Determine Occult Hepatitis B Infection in Blood Donors?
    Berkem R; Karakoç AE
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.